Steven L. Holshouser

Steven L. Holshouser, Ph.D. has a diverse work experience in the field of business development and drug discovery. Their most recent role was as the Vice President of Business Development at PROTEROS biostructures GmbH, starting in 2023. Prior to that, they served as the Director of Business Development at KIYATEC Inc. from March 2022 to October 2023. In this role, they were responsible for implementing the global preclinical business development strategy, including identifying new biopharma and academic clients, negotiating contracts, and formulating partnership agreements.

Before joining KIYATEC Inc., Dr. Holshouser worked as a Business Development Executive at Evotec from December 2019 to March 2022. Steven L. also held significant positions in academic institutions and start-up companies. As the Chief Scientific Officer at Inquisatex Epitherapeutics, a start-up based out of the Medical University of South Carolina, they were involved in raising awareness and capital for potential therapeutic drugs. Additionally, they served as the Director of Screening and Lead Optimization at the Medical University of South Carolina, where they integrated models between academic research and the pharmaceutical/biotechnology industries.

Earlier in their career, Dr. Holshouser was the Head of Discovery at FirstString Research, Inc. and gained experience as a Student co-op Intern at GSK. Steven L. began their professional journey as a Research Specialist at the Medical University of South Carolina, where they set up chemistry and molecular biology labs and developed their skills in lab management, chemical synthesis, and assay techniques. Dr. Holshouser holds a Ph.D. in Chemistry.

Steven L. Holshouser, Ph.D. has a Doctor of Philosophy (Ph.D.) in Drug Discovery from the Medical University of South Carolina, where they specialized in Clinical and Industrial Drug Development. Steven L. also holds a Bachelor's degree in Biochemistry and Chemistry from the College of Charleston.